IBER

Ibere Pharmaceuticals
IBER

Overview Fund Activity
Delisted

IBER was delisted on the 1st of March, 2023.

Back to rankings

48 hedge funds and large institutions have $120M invested in Ibere Pharmaceuticals in 2022 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 13 increasing their positions, 2 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
48
Holders Change
+2
Holders Change %
+4.35%
% of All Funds
0.83%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
10
Increased
13
Reduced
2
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
MF
Magnetar Financial
Illinois
$7.79M
2
GCL
Glazer Capital LLC
New York
$10.8M
3
FTCM
First Trust Capital Management
Illinois
$5.38M
4
CM
Cohanzick Management
New York
$3.45M
5
SCM
Saba Capital Management
New York
$3.26M

Top Sellers

1
Brown Advisory
Brown Advisory
Maryland
$0
2
KC
Kryger Capital
United Kingdom
$0
3
BCM
Basso Capital Management
Connecticut
$0
4
Alyeska Investment Group
Alyeska Investment Group
Illinois
$0
5
SCM
Shaolin Capital Management
Florida
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
BCM
51
Basso Capital Management
Connecticut
– -$1.67M -170,114 Closed
Alyeska Investment Group
52
Alyeska Investment Group
Illinois
– -$1.47M -150,000 Closed
SCM
53
Shaolin Capital Management
Florida
– -$1.34M -136,200 Closed
TCM
54
Tegean Capital Management
New York
– -$448K -45,711 Closed
EH
55
EMG Holdings
Connecticut
– -$98K -10,000 Closed
CI Investments Inc
56
CI Investments Inc
Ontario, Canada
– -$44K -4,491 Closed
1 2
3